Cerebral oedema as a possible complication of treatment with imatinib-Reference-Cited by-同舟云学术

Cerebral oedema as a possible complication of treatment with imatinib

Published:2002-05 Issue:9319 Volume:359 Page:1751-1752
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Ebnöether M,Stentoft J,Ford J,Buhl L,Gratwohl A

Publisher

Elsevier BV

Subject

General Medicine

Reference5 articles.

1. The molecular biology of chronic myeloid leukemia;Deininger;Blood,2000

2. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia;Druker;N Engl J Med,2001

3. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with Philadelphia chromosome;Druker;N Engl J Med,2001

4. Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors;Pietras;Cancer Res,2001

5. Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3′ kinase signaling;Heuchel;Proc Natl Acad Sci USA,1999

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Localized upper extremity edema secondary to Bruton’s tyrosine kinase inhibition;Leukemia & Lymphoma;2023-09-06

2. Determination of the Cut-off Value for Imatinib Plasma Levels Linked to Occurrence of Bone Pain in CML Patients;Drug Design, Development and Therapy;2022-05

3. Intracranial hypertension associated with BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia;Leukemia & Lymphoma;2022-04-01

4. A rare case of eye complications of gastric stromal tumor treatment using imatinib mesylate;Russian Ophthalmological Journal;2020-09-15

5. Dermatologic adverse events of Bcr-Abl tyrosine kinase inhibitors;Russian journal of hematology and transfusiology;2020-05-21